CMS releases details on 2008 Part D plans
The Centers for Medicare & Medicaid Services has released an improved plan finder with details on 2008 Medicare Part D prescription drug plans.
Two regional chains tie the knot
Two Hispanic pharmacy chains combine under Navarro name
Several companies voluntarily withdraw infant cough and cold OTCs
Several manufacturers withdraw over-the-counter cough and cold products
Warnings strengthened for Zyprexa and Symbyax
New metabolic warnings added to olanzapine product labels
First generic Trileptal products get FDA nod
First oxcarbazepine receives approval for seizure disorders
NACDS' Robert J. Bolger has passed away
Robert J. Bolger has died
Legislators introduce bill to reverse CMS decision on ESA coverage
Battle over ESA coverage continues
Medi-Promotions expands Medi-Scripts prescription pad model
Medi-Promotions to launch Medi-Scripts Plus prescription pad
Full approval granted for Aptivus
FDA grants full approval of tipranavir.
Biogenerics to be reimbursed within six months on the market
U.S. payers to incorporate biogeneric agents into their formularies
Part D premiums to skyrocket in 2008
2008 Medicare Part D premiums to rise 21%, according to study by Avalere Health.
CVS Caremark kicks off pharmacist month by thanking staff
CVS Caremark celebrates American Pharmacists Month
Anticholesterol drug gains new name
Mipomersen sodium is the new generic name for Isis Pharmaceuticals' anticholesterol drug ISIS 301012.
N.J. e-prescribing pilot from Aetna shows increase in use of generics
Aetna's New Jersey e-prescribing pilot shows increase in generics
FDA launches GIVE to streamline generic drug approval process
FDA launches initiative to bolster generic drug program
New guide issued for low back pain treatment
Low back pain guidelines are released from the American Pain Society and American College of Physicians
Retail health clinics clear regulatory hurdle with FTC
FTC cites retail health clinics as having potential to expand.
CDC proposes consolidating infant vaccine information materials
Instead of giving out separate written information for six infant vaccines, the Centers for Disease Control & Prevention is proposing to combine them into one document.
Latebreakers: Medicare to reject claims without NPIs
CMS will begin rejecting Medicare claims that do not use NPI numbers.
Latebreakers: FDA bill draws widespread approval
Pharmacy and consumer groups approve of new FDA bill that will track drug safety after approval and speed some generic drugs to market.
Latebreakers: Blood pressure combo OK'd
Combination medication Azor receives FDA approval
Latebreakers: New indication for Norditropin
Somatropin (Norditropin, Novo Nordisk) approved by FDA for Turner syndrome
Latebreakers: Tamper-resistant rule delayed
President Bush signs law to delay implementation of tamper-resistant prescription pad rule six months
Latebreakers: DEA proposes new requirements on methamphetamine certification
Recordkeeping requirements for chemical distributors may be revised by FDA
FDA says it's not against compounding
The Food and Drug Administration most emphatically is not against compounding of drugs, Steven Silverman, a key enforcement officer in that agency, told the National Association of Boards of Pharmacy recently.
Viewpoint: How I was cured of mercury amalgam poisoning
The author relates his personal experience with mercury toxicity through dental amalgams and calls on pharmacists to watch out for the condition among their patients.
How to set up a collaborative practice
Advice on the area of collaborative drug therapy managment.
New Products: October 8, 2007
New branded Rxs, OTCs, home health care items, health & beauty, etc.
Combating counterfeit drugs an international problem
The International Pharmaceutical Federation addressed progress in identifying and dealing with issues related to ersatz (or replacement) drug products.
Mother claims hospital error kept her from newborn daughter
New Jersey woman sues hospital for drug error that led state to take away newborn daughter.
